ironwood pharmaceuticals
Ironwood, AstraZeneca Initiate Linaclotide PhIII Trial In China
Ironwood and AstraZeneca have initiated a Phase III clinical trial of linaclotide for the treatment of adults with irritable bowel syndrome with constipation.
Ironwood, AstraZeneca To Develop Linaclotide In China
AstraZeneca and Ironwood Pharmaceuticals, Inc. announced this week an agreement to co‐develop and co‐commercialize Ironwood’s linaclotide in China.




